Volume 100, Issue 2

Search all Annals of Hematology articles

February 2021

33 articles in this issue

Hematologic disorders associated with COVID-19: a review
Mandeep Singh Rahi
Vishal Jindal
Ishmael Jaiyesimi
Review Article 07 January 2021 Pages: 309 - 320
Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Maximilian Christopeit
Martin Schmidt-Hieber
Georg Maschmeyer
Review Article Open access 20 October 2020 Pages: 321 - 336
Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis
Francesco Mannelli
Review Article 06 November 2020 Pages: 337 - 344
Clinical association between thyroid disease and immune thrombocytopenia
Shoko Ito
Shin-ichiro Fujiwara
Yoshinobu Kanda
Original Article 09 November 2020 Pages: 345 - 352
Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene
Manuel Méndez
María Isabel Moreno-Carralero
María José Morán-Jiménez
Original Article 07 November 2020 Pages: 353 - 364
Krüppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities
Ravindra Kumar
Rajiv Yadav
Shanmugam Rajasubramaniam
Original Article 03 January 2021 Pages: 365 - 373
ADAMTS-13–VWF axis in sickle cell disease patients
Valéria Sutana Ladeira
Amanda Rodrigues Barbosa
Danyelle Romana Alves Rios
Original Article 06 January 2021 Pages: 375 - 382
COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry
Maria Madeleine Rüthrich
C. Giessen-Jung
on behalf of the LEOSS Study Group
Original Article Open access 07 November 2020 Pages: 383 - 393
Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India
Shouriyo Ghosh
Mandira Chakraborty
Maitreyee Bhattacharyya
Original Article 02 November 2020 Pages: 395 - 403
The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: a systematic review
Nico Gagelmann
Nicolaus Kröger
Original Article 29 October 2020 Pages: 405 - 419
A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism
Istemi Serin
Sacide Pehlivan
Mustafa Pehlivan
Original Article 10 November 2020 Pages: 421 - 427
Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)
Anna Mele
Eleonora Prete
Vincenzo Pavone
Original Article 07 November 2020 Pages: 429 - 436
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
Stefania Oliva
Lorenzo De Paoli
Paola Omedé
Original Article 03 January 2021 Pages: 437 - 443
Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma
Jin Mao
Hua Yin
Wei Xu
Original Article 02 November 2020 Pages: 445 - 453
Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes
A. Kasprzak
K. Nachtkamp
U. Germing
Original Article Open access 07 November 2020 Pages: 455 - 463
Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis
Ziqing Wang
Weiyi Liu
Xiaomei Hu
Original Article Open access 02 January 2021 Pages: 465 - 479
Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA)
Massimo Breccia
Simone Celant
on behalf of AIFA Monitoring Registries Group
Original Article 07 January 2021 Pages: 481 - 485
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
Yu-Hung Wang
Chien-Chin Lin
Hwei-Fang Tien
Original Article Open access 23 November 2020 Pages: 487 - 498
Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow
Nils W. Engel
Jochim Reinert
Walter Fiedler
Original Article Open access 27 October 2020 Pages: 499 - 503
Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
Qi Chen
Xiao-Lu Zhu
Xiao-Hui Zhang
Original Article 02 January 2021 Pages: 505 - 516
Preemptive low-dose interleukin-2 or DLI for late-onset minimal residual disease in acute leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation
Xiao-Lin Yuan
Ya-Min Tan
Yi Luo
Original Article 31 October 2020 Pages: 517 - 527
Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis
Feiqiong Gao
Jiawei Zhang
Yang Xu
Original Article 08 January 2021 Pages: 529 - 540
Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation
Rebeca Bailén
Mi Kwon
on behalf of Grupo Español de Trasplante Hematopoyético y Terapia Celular (GETH)
Original Article 02 November 2020 Pages: 541 - 553
Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings
Yan-Ru Ma
Lan-Ping Xu
Yu Wang
Original Article 07 January 2021 Pages: 555 - 562
Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis
Liwen Wang
Hongxian Xiang
Jing Liu
Original Article Open access 06 January 2021 Pages: 563 - 573
Correction to: Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis
Liwen Wang
Hongxian Xiang
Jing Liu
Correction 18 January 2021 Pages: 575 - 575
Primary pulmonary diffuse large B cell lymphoma presenting as bulky bilateral lung tumors
Kyosuke Saeki
Makoto Nakamura
Kensuke Kojima
Letter to the Editor 16 May 2020 Pages: 577 - 578
Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL
Michael J. Hochman
Daniel B. Martin
Letter to the Editor 16 June 2020 Pages: 579 - 580
Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation
Anna Hinze
Jenny Rinke
Thomas Ernst
Letter to the Editor Open access 23 June 2020 Pages: 581 - 584
Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception
Magda Zanelli
Maurizio Zizzo
Stefano Ascani
Letter to the Editor 04 June 2020 Pages: 585 - 586
Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia
Ramona Wullenkord
Christian Reicherts
Matthias Stelljes
Letter to the Editor Open access 22 August 2020 Pages: 587 - 589
Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia
Ke Wan
Yafei Yin
Jianzhao Cheng
Letter to the Editor 17 September 2020 Pages: 591 - 593
Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up
Rabia Shahswar
Gernot Beutel
Michael Heuser
Letter to the Editor Open access 23 July 2020 Pages: 595 - 599

Volume 100, Issue 2

Hematologic disorders associated with COVID-19: a review

Prophylaxis, diagnosis and therapy of infections in patients undergoing high-dose chemotherapy and autologous haematopoietic stem cell transplantation. 2020 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Catching the clinical and biological diversity for an appropriate therapeutic approach in systemic mastocytosis

Clinical association between thyroid disease and immune thrombocytopenia

Congenital dyserythropoietic anemia types Ib, II, and III: novel variants in the CDIN1 gene and functional study of a novel variant in the KIF23 gene

Krüppel-like factor 1 (KLF1) gene single nucleotide polymorphisms in sickle cell disease and its association with disease-related morbidities

ADAMTS-13–VWF axis in sickle cell disease patients

COVID-19 in cancer patients: clinical characteristics and outcome—an analysis of the LEOSS registry

Analysis of blood stream infections, antibiograms and clinical outcomes in haematological patients with febrile neutropenia: data from a tertiary care haematology institute in India

The role of novel agents for consolidation after autologous transplantation in newly diagnosed multiple myeloma: a systematic review

A new parameter in multiple myeloma: CYP3A4*1B single nucleotide polymorphism

Carfilzomib, lenalidomide, and dexamethasone in relapsed/refractory multiple myeloma patients: the real-life experience of Rete Ematologica Pugliese (REP)

A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma

Prognostic value of 25-hydroxy vitamin D in extranodal NK/T cell lymphoma

Analysis of the impact of adherence to guidelines and expert advice in patients with myelodysplastic syndromes

Prognostic value of ASXL1 mutations in patients with primary myelofibrosis and its relationship with clinical features: a meta-analysis

Mortality rate in patients with chronic myeloid leukemia in chronic phase treated with frontline second generation tyrosine kinase inhibitors: a retrospective analysis by the monitoring registries of the Italian Medicines Agency (AIFA)

Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125

Newly diagnosed isolated myeloid sarcoma–paired NGS panel analysis of extramedullary tumor and bone marrow

Prognosis and risk factors for central nervous system relapse after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia

Preemptive low-dose interleukin-2 or DLI for late-onset minimal residual disease in acute leukemia or myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation

Post-transplant cyclophosphamide versus antithymocyte globulin in allogeneic hematopoietic cell transplantation: a meta-analysis

Post-transplant cyclophosphamide for GVHD prophylaxis compared to ATG-based prophylaxis in unrelated donor transplantation

Allogeneic hematopoietic stem cell transplantation for intermediate-risk acute myeloid leukemia in the first remission: outcomes using haploidentical donors are similar to those using matched siblings

Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis

Correction to: Comparison of the efficiency, safety, and survival outcomes in two stem cell mobilization regimens with cyclophosphamide plus G-CSF or G-CSF alone in multiple myeloma: a meta-analysis

Primary pulmonary diffuse large B cell lymphoma presenting as bulky bilateral lung tumors

Coincidence of autoimmune hemolytic anemia and pure red cell aplasia in a patient with CLL

Durable remission with ruxolitinib in a chronic neutrophilic leukemia patient harboring a truncation and membrane proximal CSF3R compound mutation

Prenatal diagnosis of familial hemophagocytic lymphohistiocytosis: morphological findings in the product of conception

Sequential therapy with inotuzumab ozogamicin, CD19 CAR T cells, and blinatumomab in an elderly patient with relapsed acute lymphoblastic leukemia

Remarkable response to roxadustat in a case of anti-erythropoietin antibody-mediated pure red cell aplasia

Risk of tumor lysis syndrome in patients with acute myeloid leukemia treated with venetoclax-containing regimens without dose ramp-up

Navigation